482 related articles for article (PubMed ID: 24286516)
21. Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination.
Hakroush S; Tampe B
Front Immunol; 2021; 12():762006. PubMed ID: 34659268
[TBL] [Abstract][Full Text] [Related]
22. M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN.
Zhao L; David MZ; Hyjek E; Chang A; Meehan SM
Clin J Am Soc Nephrol; 2015 Jan; 10(1):54-62. PubMed ID: 25516918
[TBL] [Abstract][Full Text] [Related]
23. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters?
Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M
Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223
[TBL] [Abstract][Full Text] [Related]
24. Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
Geetha D; Sethi S; De Vriese AS; Specks U; Kallenberg CGM; Lim N; Spiera R; St Clair EW; Merkel PA; Seo P; Monach PA; Lepori N; Fessler BJ; Langford CA; Hoffman GS; Sharma R; Stone JH; Fervenza FC;
Am J Nephrol; 2017; 46(3):231-238. PubMed ID: 28881339
[TBL] [Abstract][Full Text] [Related]
25. Urinary angiotensinogen: an indicator of active antineutrophil cytoplasmic antibody-associated glomerulonephritis.
Wu L; Yang M; Feng X; Jin L; Wu C; Cui S; Zhou Z; Zhong X; Shi M; Yang Z; Cao W
Nephrol Dial Transplant; 2019 May; 34(5):838-847. PubMed ID: 29733413
[TBL] [Abstract][Full Text] [Related]
26. Increased renal damage in hypocomplementemic patients with ANCA-associated vasculitis: retrospective cohort study.
García L; Pena CE; Maldonado RÁ; Costi C; Mamberti M; Martins E; García MA
Clin Rheumatol; 2019 Oct; 38(10):2819-2824. PubMed ID: 31222573
[TBL] [Abstract][Full Text] [Related]
27. Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.
Khalighi MA; Wang S; Henriksen KJ; Bock M; Keswani M; Chang A; Meehan SM
Pediatr Nephrol; 2015 Jun; 30(6):953-9. PubMed ID: 25669759
[TBL] [Abstract][Full Text] [Related]
28. CC Chemokine Ligand 18 in ANCA-Associated Crescentic GN.
Brix SR; Stege G; Disteldorf E; Hoxha E; Krebs C; Krohn S; Otto B; Klätschke K; Herden E; Heymann F; Lira SA; Tacke F; Wolf G; Busch M; Jabs WJ; Özcan F; Keller F; Beige J; Wagner K; Helmchen U; Noriega M; Wiech T; Panzer U; Stahl RA
J Am Soc Nephrol; 2015 Sep; 26(9):2105-17. PubMed ID: 25762060
[TBL] [Abstract][Full Text] [Related]
29. Poor renal outcome of antineutrophil cytoplasmic antibody negative Pauci-immune glomerulonephritis in Taiwanese.
Hung PH; Chiu YL; Lin WC; Chiang WC; Chen YM; Lin SL; Wu KD; Tsai TJ
J Formos Med Assoc; 2006 Oct; 105(10):804-12. PubMed ID: 17000453
[TBL] [Abstract][Full Text] [Related]
30. Leukocyturia and hematuria enable non-invasive differentiation of Bowman's capsule rupture severity in PR3-ANCA glomerulonephritis.
Baier E; Kluge IA; Hakroush S; Tampe D; Tampe B
J Nephrol; 2023 Apr; 36(3):799-808. PubMed ID: 36542276
[TBL] [Abstract][Full Text] [Related]
31. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of astaxanthin on ANCA-associated vasculitis.
Sun RL; Shang JC; Han RH; Xing GQ
Int Immunopharmacol; 2024 May; 132():111928. PubMed ID: 38537540
[TBL] [Abstract][Full Text] [Related]
33. [Anti-neutrophil cytoplasmic antibodies (ANCA) in the glomerulonephritis].
Kacprzyk F; Chrzanowski W
Pol Arch Med Wewn; 1996 Jun; 95(6):514-23. PubMed ID: 9005420
[TBL] [Abstract][Full Text] [Related]
34. A case of smoldering antineutrophil cytoplasmic antibody-associated vasculitis development during the course of primary Sjögren's syndrome.
Iwafuchi Y; Morioka T; Oyama Y; Narita I
CEN Case Rep; 2022 May; 11(2):247-253. PubMed ID: 34787826
[TBL] [Abstract][Full Text] [Related]
35. Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation.
Ohlsson S; Holm L; Hansson C; Ohlsson SM; Gunnarsson L; Pettersson Å; Skattum L
PLoS One; 2019; 14(6):e0218272. PubMed ID: 31216309
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Value of Histologic Classification of ANCA-Associated Glomerulonephritis.
Bjørneklett R; Sriskandarajah S; Bostad L
Clin J Am Soc Nephrol; 2016 Dec; 11(12):2159-2167. PubMed ID: 27797896
[TBL] [Abstract][Full Text] [Related]
37. Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report.
Manabe S; Hatano M; Nakano M; Fujii T; Nitta K; Nagata M
Pathol Int; 2017 Aug; 67(8):419-424. PubMed ID: 28580649
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil extracellular trap formation is associated with autophagy-related signalling in ANCA-associated vasculitis.
Tang S; Zhang Y; Yin SW; Gao XJ; Shi WW; Wang Y; Huang X; Wang L; Zou LY; Zhao JH; Huang YJ; Shan LY; Gounni AS; Wu YZ; Zhang JB
Clin Exp Immunol; 2015 Jun; 180(3):408-18. PubMed ID: 25644394
[TBL] [Abstract][Full Text] [Related]
39. Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis.
Syed R; Rehman A; Valecha G; El-Sayegh S
Biomed Res Int; 2015; 2015():402826. PubMed ID: 26688808
[TBL] [Abstract][Full Text] [Related]
40. Acute interstitial nephritis caused by ANCA-associated vasculitis: a case based review.
Muhammad A; Xiao Z; Lin W; Zhang Y; Meng T; Ning J; Xu H; Tang R; Xiao X
Clin Rheumatol; 2024 Mar; 43(3):1227-1244. PubMed ID: 37932622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
